Reisem is one of more than 500 cancer patients from Wisconsin who have had newly available genetic testing done on their tumors, which can lead doctors to use therapies that target specific mutations instead of standard chemotherapy. The initiative, started at the UW Carbone Cancer Center in 2015, is supported by $1 million in the current state budget.
Office of Strategic Communication